D
Pacira BioSciences, Inc. PCRX
$25.23 $0.783.19% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -103.73M -99.56M -90.73M 63.59M 70.47M
Total Depreciation and Amortization 81.53M 78.79M 76.03M 74.21M 74.40M
Total Amortization of Deferred Charges 3.38M 3.22M 3.06M 2.91M 2.84M
Total Other Non-Cash Items 219.97M 225.46M 225.32M 73.77M 58.86M
Change in Net Operating Assets -25.41M -18.52M -9.83M -20.12M -21.95M
Cash from Operations 175.75M 189.39M 203.84M 194.36M 184.62M
Capital Expenditure -16.35M -10.64M -10.32M -9.62M -11.43M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -16.70M -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -60.33M -72.64M -64.22M -17.10M 7.26M
Cash from Investing -93.38M -83.28M -74.53M -26.71M -4.17M
Total Debt Issued 287.50M 287.50M 287.50M 287.50M 0.00
Total Debt Repaid -210.89M -210.89M -210.89M -235.88M -36.25M
Issuance of Common Stock 2.30M 2.30M 2.50M 2.53M 4.42M
Repurchase of Common Stock -25.67M -25.49M -25.52M -25.49M -110.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -36.06M -36.06M -36.06M -36.06M 0.00
Cash from Financing 17.19M 17.36M 17.54M -7.40M -31.94M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 99.56M 123.48M 146.85M 160.24M 148.51M